Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

Roche. (6/3/17). "Press Release: Roche Presents New Data for Tecentriq (atezolizumab) and Updates from Across Its Cancer Immunotherapy Development Programme at ASCO 2017". Basel.

Organisations Organisation Roche (Group)
  Organisation 2 American Society of Clinical Oncology (ASCO)
Products Product Tecentriq®
  Product 2 ASCO 2017 Chicago
Person Person Horning, Sandra (Roche 201403 CMO + Head Global Product Development)
     


   
Record changed: 2017-06-12

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Roche (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px




» top